Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Chemistry

• Publication date

  2010-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1373/clinchem.2009.139295PMID 20348404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Screening and diagnosis of hepatocellular carcinoma

  2009cited by this paper
• GlycoFibroTest Is a Highly Performant Liver Fibrosis Biomarker Derived from DNA Sequencer-based Serum Protein Glycomics*S

  2009cited by this paper
• Alteration of protein glycosylation in liver diseases.

  2009cited by this paper
• Branched N‐glycans regulate the biological functions of integrins and cadherins

  2008influential reference
• Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications.

  2008cited by this paper
• [N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus].

  2008cited by this paper
• N‐glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus

  2007cited by this paper
• Glycome mapping on DNA sequencing equipment

  2006cited by this paper
• Treatment of hepatocellular carcinoma.

  2005cited by this paper
• Management of hepatocellular carcinoma

  2005cited by this paper
• Staging and current treatment of hepatocellular carcinoma.

  2005cited by this paper
• Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

  2001cited by this paper
• Hemopexin: a review of biological aspects and the role in laboratory medicine.

  2001cited by this paper
• Ultrasensitive profiling and sequencing of N-linked oligosaccharides using standard DNA-sequencing equipment.

  2001cited by this paper
• Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey

  2000cited by this paper
• Treatment of hepatocellular carcinoma

  1997cited by this paper
• Transfection of N-Acetylglucosaminyltransferase III Gene Suppresses Expression of Hepatitis B Virus in a Human Hepatoma Cell Line, HB611 (*)

  1995cited by this paper
• Selective suppression of N-acetylglucosaminyltransferase III activity in a human hepatoblastoma cell line transfected with hepatitis B virus.

  1994cited by this paper
• Primary lung cancer producing alpha-fetoprotein.

  1992cited by this paper
• Primary lung cancer producing α-fetoprotein

  1992cited by this paper
• Beta-human chorionic gonadotropin and alpha-fetoprotein in central and peripheral venous blood of patients with testicular tumors.

  1992cited by this paper
• Cancer‐associated elevation of α(1 → 3)‐l‐fucosyltransferase activity in human serum

  1988cited by this paper
• Cancer-associated elevation of alpha(1----3)-L-fucosyltransferase activity in human serum.

  1988cited by this paper
• Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.

  1986cited by this paper
• Complete amino acid sequence of human hemopexin, the heme-binding protein of serum.

  1985cited by this paper
• Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein.

  1984cited by this paper
• Affinity chromatography of heme-binding proteins: an improved method for the synthesis of hemin-agarose.

  1982cited by this paper
• Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.

  1975cited by this paper
• Serum α-Fetoprotein in Patients with Neoplasms of the Gastrointestinal Tract

  1975cited by this paper
• Letter: the consultants' contract.

  1975cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Serum N-glycomics for non-invasive detection of significant liver pathology across clinical phases of treatment-naïve chronic hepatitis B

  2025cites this paper
• Nitrogen-modified reduced graphene oxide for serum enrichment of N-glycans and MALDI-TOF MS-based identification of HCC biomarkers.

  2025cites this paper
• Spatial omics-based machine learning algorithms for the early detection of hepatocellular carcinoma

  2024cites this paper
• Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma

  2024cites this paper
• Mass spectrometry based biomarkers for early detection of HCC using a glycoproteomic approach.

  2023cites this paper
• Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications

  2023cites this paper
• Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma

  2023cites this paper
• Oncoproteomics: insight into current proteomic technologies in cancer biomarker discovery and treatment

  2022cites this paper
• GlycoFibroTyper: A Novel Method for the Glycan Analysis of IgG and the Development of a Biomarker Signature of Liver Fibrosis

  2022cites this paper
• Modeling and integration of N-glycan biomarkers in a comprehensive biomarker data model.

  2022cites this paper
• Charting the Proteoform Landscape of Serum Proteins in Individual Donors by High-Resolution Native Mass Spectrometry

  2022cites this paper
• Non-alcoholic fatty liver disease and liver secretome

  2022cites this paper
• Diagnostic management of nonalcoholic fatty liver disease: a transformational period in the development of diagnostic and predictive tools—a narrative review

  2021cites this paper
• Vitronectin (VTN): A Novel Diagnostic and Prognostic Marker for Hepatocellular Carcinoma (HCC) On Top Of Chronic Hepatitis C Virus Related Diseases

  2021cites this paper
• Novel lamprey antibody recognizes terminal sulfated galactose epitopes on mammalian glycoproteins

  2021cites this paper
• A Potential Serum N-glycan Biomarker for Hepatitis C Virus-Related Early-Stage Hepatocellular Carcinoma with Liver Cirrhosis

  2020cites this paper
• The Role of Glycans in Chronic Inflammatory Gastrointestinal and Liver Disorders and Cancer

  2020cites this paper
• CEBP FOCUS Biomarkers for the Early Detection of Hepatocellular Carcinoma

  2020cites this paper
• Serum Glycomics on Postoperative Day 7 Are Associated With Graft Loss Within 3 Months After Liver Transplantation Regardless of Early Allograft Dysfunction

  2020cites this paper
• Novel high-throughput applications for NAFLD diagnostics and biomarker discovery

  2020influential citation
• Status Quo of Glycosylation in Cancer: What Is, What Is Not and What Is to Be

  2020cites this paper
• Biomarkers for the Early Detection of Hepatocellular Carcinoma

  2020cites this paper
• Identification of noninvasive diagnostic biomarkers for hepatocellular carcinoma by urinary proteomics.

  2020cites this paper
• Analysis of Hepatocellular Carcinoma Tissue for Biomarker Discovery

  2019cites this paper
• Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review

  2019cites this paper
• Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.

  2019cites this paper
• The potential of glycomics as prognostic biomarkers in liver disease and liver transplantation.

  2019cites this paper
• protein glycosylation as a diagnostic and prognostic marker of chronic inflammatory gastrointestinal and liver diseases.

  2019cites this paper
• Multi-omic Pathway and Network Analysis to Identify Biomarkers for Hepatocellular Carcinoma

  2019cites this paper
• Quantifying Protein-Specific N-glycome Profiles by Focused Protein- and Immunoprecipitation-Glycomics.

  2019cites this paper
• N-Linked Glycan Branching and Fucosylation Are Increased Directly in Hcc Tissue As Determined through in Situ Glycan Imaging.

  2018cites this paper
• Quantitative analysis of core fucosylation of serum proteins in liver diseases by LC-MS-MRM.

  2018cites this paper
• Glycome Patterns of Perfusate in Livers Before Transplantation Associate With Primary Nonfunction.

  2018cites this paper
• Alterations of the serum N-glycan profile in female patients with Major Depressive Disorder.

  2018cites this paper
• Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey

  2018cites this paper
• Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.

  2018cites this paper
• Role of Serum Glypican-3 in the Diagnosis of Hepatocellular Carcinoma in the Upper Egypt

  2018cites this paper
• Serum Clusterin In Patients With Chronic HCV infection Related Cirrhosis

  2018cites this paper
• Protein glycosylation in viral hepatitis-related HCC: Characterization of heterogeneity, biological roles, and clinical implications.

  2017cites this paper
• Increased sialylation of site specific O-glycoforms of hemopexin in liver disease

  2016influential citation
• The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases

  2016cites this paper
• Prognostic value of serum tumor abnormal protein in gastric cancer patients.

  2016cites this paper
• Preeclampsia transforms membrane N-glycome in human placenta.

  2016cites this paper
• Human plasma protein N-glycosylation

  2015influential citation
• Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development

  2015cites this paper
• Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation

  2015cites this paper
• Quantitative chemical proteomics for investigating the biomarkers of dioscin against liver fibrosis caused by CCl4 in rats.

  2015cites this paper
• Defining glycoprotein cancer biomarkers by MS in conjunction with glycoprotein enrichment.

  2015cites this paper
• Enhanced detection of in‐gel released N‐glycans by MALDI‐TOF‐MS

  2015cites this paper
• Glycosylation and liver cancer.

  2015cites this paper
• Protein and Site Specificity of Fucosylation in Liver-Secreted Glycoproteins

  2014cites this paper
• Serum clusterin as a marker for diagnosing hepatocellular carcinoma

  2014cites this paper
• Bayesian Alignment Model for Analysis of LC-MS-based Omic Data

  2014cites this paper
• Identification of 34 N-glycan isomers in human serum by capillary electrophoresis coupled with laser-induced fluorescence allows improving glycan biomarker discovery

  2014influential citation
• LC–MS Profiling of N-Glycans Derived from Human Serum Samples for Biomarker Discovery in Hepatocellular Carcinoma

  2014cites this paper
• Quantification of Fucosylated Hemopexin and Complement Factor H in Plasma of Patients with Liver Disease

  2014cites this paper
• LC–MS/MS Quantitation of Esophagus Disease Blood Serum Glycoproteins by Enrichment with Hydrazide Chemistry and Lectin Affinity Chromatography

  2014cites this paper
• Label-free glycopeptide quantification for biomarker discovery in human sera.

  2014cites this paper
• Inflammation: an important parameter in the search of prostate cancer biomarkers

  2014cites this paper
• Capillary electrophoresis of urinary prostate glycoproteins assists in the diagnosis of prostate cancer

  2014cites this paper
• Cell Surface Glycan Alterations in Epithelial Mesenchymal Transition Process of Huh7 Hepatocellular Carcinoma Cell

  2013cites this paper
• Endo-β-N-acetylglucosaminidase H de-N-glycosylation in a domestic microwave oven: application to biomarker discovery.

  2013cites this paper
• Fucosylated-hemopexin and HCC 1 1 Clinical utility of serum Fucosylated-hemopexin in Japanese patients with Hepatocellular Carcinoma

  2013cites this paper
• N- and O-glycome analysis of serum and urine from bladder cancer patients using a high-throughput glycoblotting method

  2013influential citation
• Quantitative Liquid Chromatography-Mass Spectrometry-Multiple Reaction Monitoring (LC-MS-MRM) Analysis of Site-specific Glycoforms of Haptoglobin in Liver Disease*

  2013cites this paper
• Cell Surface-Specific N-Glycan Profiling in Breast Cancer

  2013cites this paper
• Serum glycome profiling: a biomarker for diagnosis of ovarian cancer.

  2013cites this paper
• Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer

  2012cites this paper
• N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.

  2012cites this paper
• Potential plasma biomarkers for progression of knee osteoarthritis using glycoproteomic analysis coupled with a 2D-LC-MALDI system

  2012cites this paper
• Semi-automated identification of N-Glycopeptides by hydrophilic interaction chromatography, nano-reverse-phase LC-MS/MS, and glycan database search.

  2012cites this paper
• Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinoma

  2012cites this paper
• Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients.

  2012cites this paper
• N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis.

  2012cites this paper
• Tandem lectin affinity chromatography monolithic columns with surface immobilised concanavalin A, wheat germ agglutinin and Ricinus communis agglutinin-I for capturing sub-glycoproteomics from breast cancer and disease-free human sera.

  2012cites this paper
• LecT-Hepa: A triplex lectin-antibody sandwich immunoassay for estimating the progression dynamics of liver fibrosis assisted by a bedside clinical chemistry analyzer and an automated pretreatment machine.

  2011cites this paper
• High‐throughput lectin magnetic bead array‐coupled tandem mass spectrometry for glycoprotein biomarker discovery

  2011cites this paper
• Glycomic Alterations in the Highly-abundant and Lesser-abundant Blood Serum Protein Fractions for Patients Diagnosed with Hepatocellular Carcinoma.

  2011cites this paper
• Profiling of Endo H‐released serum N‐glycans using CE‐LIF and MALDI‐TOF‐MS – Application to rheumatoid arthritis

  2011cites this paper
• An alternative view of the proposed alternative activities of hemopexin

  2011cites this paper
• Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C

  2011cites this paper